These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28345332)

  • 1. Effects of Cisplatin-Loaded Niosomal Nanoparticleson BT-20 Human Breast Carcinoma Cells.
    Kanaani L; Javadi I; Ebrahimifar M; Ebrahimi Shahmabadi H; Akbarzadeh Khiyav A; Mehrdiba T
    Asian Pac J Cancer Prev; 2017 Feb; 18(2):365-368. PubMed ID: 28345332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study.
    Poy D; Akbarzadeh A; Ebrahimi Shahmabadi H; Ebrahimifar M; Farhangi A; Farahnak Zarabi M; Akbari A; Saffari Z; Siami F
    Chem Biol Drug Des; 2016 Oct; 88(4):568-73. PubMed ID: 27178305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Factor-Loaded Nano-niosomal Gel Formulation and Characterization.
    Moghassemi S; Hadjizadeh A; Hakamivala A; Omidfar K
    AAPS PharmSciTech; 2017 Jan; 18(1):34-41. PubMed ID: 27502406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, Characterization and Cytotoxicity of Silibinin- Containing Nanoniosomes in T47D Human Breast Carcinoma Cells.
    Amiri B; Ebrahimi-Far M; Saffari Z; Akbarzadeh A; Soleimani E; Chiani M
    Asian Pac J Cancer Prev; 2016; 17(8):3835-8. PubMed ID: 27644625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Cisplatin-loaded poly butyl cyanoacrylate nanoparticles on the ovarian cancer: an in vitro study.
    Bagherpour Doun SK; Alavi SE; Koohi Moftakhari Esfahani M; Ebrahimi Shahmabadi H; Alavi F; Hamzei S
    Tumour Biol; 2014 Aug; 35(8):7491-7. PubMed ID: 24789433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold Nanoparticles Conjugated L-Lysine for Improving Cisplatin Delivery to Human Breast Cancer Cells.
    Ganji M; Dashtestani F; Neghab HK; Soheilifar MH; Hakimian F; Haghiralsadat F
    Curr Drug Deliv; 2021; 18(6):753-760. PubMed ID: 33272179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro study of cisplatin-loaded Fe3O4 nanoparticles modified with PLGA-PEG6000 copolymers in treatment of lung cancer.
    Nejati-Koshki K; Mesgari M; Ebrahimi E; Abbasalizadeh F; Fekri Aval S; Khandaghi AA; Abasi M; Akbarzadeh A
    J Microencapsul; 2014; 31(8):815-23. PubMed ID: 25090589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of Cisplatin-Loaded Poly Butyl Cyanoacrylate Nanoparticles in a Brain Cancer Cell Line: Anionic Polymerization Results.
    Mohamadi N; Kazemi SM; Mohammadian M; Toofani Milani A; Moradi Y; Yasemi M; Ebrahimi far M; Mazloumi Tabrizi M; Ebrahimi Shahmabadi H; Akbarzadeh Khiyavi A
    Asian Pac J Cancer Prev; 2017 Mar; 18(3):629-632. PubMed ID: 28440967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines.
    Eatemadi A; Darabi M; Afraidooni L; Zarghami N; Daraee H; Eskandari L; Mellatyar H; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):1008-17. PubMed ID: 25707442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of temozolomide-loaded nanoparticles and their targeting potential to melanoma cells.
    Jiang G; Li R; Tang J; Ma Y; Hou X; Yang C; Guo W; Xin Y; Liu Y
    Oncol Rep; 2017 Feb; 37(2):995-1001. PubMed ID: 28035395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable polymeric system for cisplatin delivery: development, in vitro characterization and investigation of toxicity profile.
    Alam N; Khare V; Dubey R; Saneja A; Kushwaha M; Singh G; Sharma N; Chandan B; Gupta PN
    Mater Sci Eng C Mater Biol Appl; 2014 May; 38():85-93. PubMed ID: 24656356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells.
    Surnar B; Sharma K; Jayakannan M
    Nanoscale; 2015 Nov; 7(42):17964-79. PubMed ID: 26465291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of the metastasis-linked gene, AEG-1, using siRNA-loaded cholamine surface-modified gelatin nanoparticles in the breast carcinoma cell line MCF-7.
    Abozeid SM; Hathout RM; Abou-Aisha K
    Colloids Surf B Biointerfaces; 2016 Sep; 145():607-616. PubMed ID: 27285732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562.
    Hasandoost L; Akbarzadeh A; Attar H; Heydarinasab A
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):665-669. PubMed ID: 27133178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
    Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
    Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of Anti-miR-21 and 4-Hydroxytamoxifen Co-loaded Biodegradable Polymer Nanoparticles and Their Antiproliferative Effect on Breast Cancer Cells.
    Devulapally R; Sekar TV; Paulmurugan R
    Mol Pharm; 2015 Jun; 12(6):2080-92. PubMed ID: 25880495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel.
    Kulhari H; Pooja D; Shrivastava S; V G M N; Sistla R
    Colloids Surf B Biointerfaces; 2014 May; 117():166-73. PubMed ID: 24632389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-based anionic long-circulating cisplatin liposomes with reduced renal toxicity.
    Kuang Y; Liu J; Liu Z; Zhuo R
    Biomaterials; 2012 Feb; 33(5):1596-606. PubMed ID: 22079777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of cisplatin release by in-vitro using poly(D,L-lactide) coated Fe3O4 nanocarriers.
    Devi SV; Prakash T
    IEEE Trans Nanobioscience; 2013 Mar; 12(1):60-3. PubMed ID: 23474439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.